The biopharmaceutical industry’s growth has led to a rise in contract development and manufacturing organizations (CDMOs). This trend requires pharmaceutical companies to exercise caution when choosing a CDMO partner. Factors to consider include the drug’s development stage, the range of services offered by the CDMO, cost transparency, speed and quality of development, expertise, regulatory compliance, technological capabilities, and effective communication.
Researchers Detect ZionSiphon Malware Targeting Israeli Water, Desalination OT Systems – The Hacker News
Researchers Detect ZionSiphon Malware Targeting Israeli Water, Desalination OT Systems The Hacker News
